Space Pharmaceuticals appoints Dr. Marco Pickel as Director of Business Development
We are pleased to welcome Dr. Marco Pickel as Director of Business Development. With decades of API industry experience in top leading companies in the pharmaceutical, cosmetics, food, adhesives and coatings fields, Dr. Pickel will play a key role in the development of Space Peptides CDMO business.
Opening ceremony celebrates the construction for Space Peptides, a Space Pharmaceuticals company, of a large-scale peptide manufacturing facility in Jiangsu, China
Space Peptides, a Space Pharmaceuticals company, will invest approximately USD 150 million to build state-of-the-art manufacturing facilities, expanding to an annual capacity of 1100 kg to support scaling of peptide active pharmaceutical ingredient production to clinical and commercial manufacturing, covering therapeutic areas of women’s health, metabolic diseases, antimicrobial and onco-immunology. The new facility will have […]
Space Peptides, a Space Pharmaceuticals company, completes GMP-like inspection by China’s National Medical Products Administration (NMPA, previously called CFDA)
Space Peptides, a Space Pharmaceuticals company, successfully completes the GMP inspection carried out by China’s regulatory agency National Medical Products Administration (NMPA, previously called CFDA). The comprehensive inspection covered the Space Peptides Xiamen facility’s quality processes and entire production system., which meets the requirements for producing peptide intermediates / advanced intermediates and active pharmaceutical ingredients […]
Space Peptides, a Space Pharmaceuticals company, announces its new in vitro / in vivo testing laboratory at the Xiamen Science Park in China
“With our new in vitro / in vivo testing laboratory closely connected with the peptide production site, Space Pharmaceuticals provides integrated peptide drug discovery from computational prediction, peptide synthesis and laboratory testing results, forming close iterative cycles”, said Dr. Runze He, CEO at Space Pharmaceuticals. “Operational this month, the testing facility at Xiamen National Science […]
Space Pharmaceuticals appoints Dr. Hongming Chen as Technology Advisor
GDBspace AG, a company specializing in computational methods for molecule discovery, is pleased to welcome Dr. Hongming Chen as Technology Advisor.
Space Peptides, a Space Pharmaceuticals company, opens its new peptide pilot plan and laboratory at the Xiamen National Science Park in China
Space Peptides, a Space Pharmaceuticals company, announces that it is entering into a new facility at the Xiamen National Science Park to enhance its process development capabilities and peptide production. The site has a size of 3000 square meters, providing cleanroom capabilities, process development laboratory and a production capacity of 15 kg/year. “Our new pilot […]